Calendar Sonoma Pharmaceuticals, Inc.

Equities

SNOA

US83558L2043

Market Closed - Nasdaq 02:00:01 27/04/2024 am IST 5-day change 1st Jan Change
0.159 USD -0.87% Intraday chart for Sonoma Pharmaceuticals, Inc. +6.00% -11.86%

Chart calendar Sonoma Pharmaceuticals, Inc.

7bd87c3890b.ypcJeEuZfM7H1ekLIfUSLRDWMyc5cS41SXEqngJM0wM.oM5ROnzxP6L1jJ8zVaNGRUa3ZERVKGVjOARH0Xt8iVG82k1Me_9RvPflhg~776e72e3c009fb0649effd62932fabd8

Upcoming events on Sonoma Pharmaceuticals, Inc.

10/07/2024 Q4 2024 Earnings Release (Projected)
14/08/2024 Q1 2025 Earnings Release (Projected)
11/11/2024 Q2 2025 Earnings Release (Projected)
18/02/2025 Q3 2025 Earnings Release (Projected)

Past events on Sonoma Pharmaceuticals, Inc.

10/04/2024 12:30 am LD Micro Invitational Conference
03/04/2024 03:14 am Trickle Research Spring Microcap Conference
09/02/2024 02:45 am Q3 2024 Earnings Release
14/11/2023 03:00 am Q2 2024 Earnings Release
03/11/2023 Symposium on Advanced Wound Care Fall Conference
12/10/2023 Dawson James Small Cap Growth Conference
29/09/2023 01:30 am Annual General Meeting
11/08/2023 01:45 am Q1 2024 Earnings Release
22/06/2023 05:00 pm Q4 2023 Earnings Release
15/02/2023 03:00 am Q3 2023 Earnings Release
02/02/2023 11:00 pm Sequire Biotechnology Conference
15/11/2022 02:45 am Interim 2023 Earnings Release
01/11/2022 CPHI Conference
16/09/2022 01:30 am Annual General Meeting
12/08/2022 02:00 am Q1 2023 Earnings Release
14/07/2022 02:15 am FY 2022 Earnings Release
12/02/2022 03:00 am Q3 2022 Earnings Release
10/01/2022 H.C. Wainwright BioConnect Conference
15/11/2021 06:30 pm Interim 2022 Earnings Release
16/09/2021 01:30 am Annual General Meeting

Annual results

Fiscal PeriodMarch 2019 2023 2024
Net sales
Million USD
Released
Forecast
Spread
19,0
19,4
-2.22%
0,00



14,7

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00



0,00

EBIT
Million USD
Released
Forecast
Spread
-11,3
-11,6
2.95%
0,00



-4,61

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-11,3
-11,6
2.24%
0,00



-5,08

Net income
Million USD
Released
Forecast
Spread
-11,8
-11,6
-1.71%
-5,15



-5,08

EPS
USD
Released
Forecast
Spread
-12,8
-12,8
0.39%
-1,52



-0,89

Announcement Date01/07/1921/06/23-

Quarterly results

Fiscal PeriodMarzo 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread



2,73
3,48
-21.52%
3,14
3,76
-16.54%

3,98


4,20


4,25


4,60


4,86

EBIT
Million USD
Released
Forecast
Spread



-1,21
-1,19
-1.51%
-0,84
-1,16
27.24%

-1,02


-0,92


-0,94


-0,85


-0,65

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-1,30
-1,28
-1.41%
-0,92
-1,25
26.16%

-1,11


-0,96


-0,98


-0,89


-0,69

Net income
Million USD
Released
Forecast
Spread
-1,42


-1,48
-1,28
-15.94%
-0,87
-1,25
30.72%

-1,11


-0,96


-0,98


-0,89


-0,69

EPS
USD
Released
Forecast
Spread
-0,29


-0,29
-0,24
-20.83%
-0,08
-0,21
61.9%

-0,17


-0,14


-0,13


-0,11


-0,08

Announcement Date10/08/2313/11/2308/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SNOA Stock
  4. Calendar Sonoma Pharmaceuticals, Inc.